Adma Biologics, Inc.
ADMA· Nasdaq
Released Aug 14, 2012, after the close
10-Q filed Aug 14, 2012, 45 days after period end · 0001193805-12-001369
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2012 | Q2 2011 |
|---|---|---|
| Revenue | $230.10K | — |
| Net Income | -$1.21M | -$2.39M |
| EPS Diluted | -$0.20 | -$6.79 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adma Biologics, Inc. · CIK 1368514 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end